EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Ketamine for Treatment of Mood Disorders and Suicidality: A Narrative Review of Recent Progress

Michael D Kritzer, Nicholas A Mischel, Jonathan R Young, Christopher S Lai, Prakash S Masand, Steven T Szabo, Sanjay J Mathew

Annals of Clinical Psychiatry · 2022-02 · 34 (1) · 33-43

DOI: 10.12788/acp.0048 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Clinical Psychiatry, 2022-02. Verfasst von Michael D Kritzer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Major Depressive Disorder, Depressive Disorder, Treatment-Resistant, Ketamine, Suicide Prevention. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderDepressive Disorder, Treatment-ResistantKetamineSuicide PreventionHumansMeta-Analysis as TopicMood DisordersObservational Studies as TopicRandomized Controlled Trials as TopicSuicidal Ideation

Substanzen

Ketamine

Autor:innen und Institutionen

  • Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
  • Wayne State University, Detroit, Michigan, USA.
  • Duke University School of Medicine, Durham, North Carolina, USA.
  • Columbia University, New York, New York, USA.
  • CEO, Centers for Psychiatric Excellence (COPE), Adjunct Professor, New York, New York, USA.
  • Duke-NUS (National University of Singapore), Singapore.

Förderung

  • CSRD VA
  • NIMH NIH HHS

Zitieren

APA

Kritzer, M. D., Mischel, N. A., Young, J. R., Lai, C. S., Masand, P. S., Szabo, S. T., & Mathew, S. J. (2022). Ketamine for Treatment of Mood Disorders and Suicidality: A Narrative Review of Recent Progress. Annals of Clinical Psychiatry, 34(1), 33-43. https://doi.org/10.12788/acp.0048

Vancouver

Kritzer MD, Mischel NA, Young JR, Lai CS, Masand PS, Szabo ST, et al. Ketamine for Treatment of Mood Disorders and Suicidality: A Narrative Review of Recent Progress. Annals of Clinical Psychiatry. 2022;34(1):33-43. doi:10.12788/acp.0048

BibTeX
@article{Kritzer2022,
  author = {Kritzer, Michael D and Mischel, Nicholas A and Young, Jonathan R and Lai, Christopher S and Masand, Prakash S and Szabo, Steven T and Mathew, Sanjay J},
  title = {Ketamine for Treatment of Mood Disorders and Suicidality: A Narrative Review of Recent Progress},
  journal = {Annals of Clinical Psychiatry},
  year = {2022},
  volume = {34},
  number = {1},
  pages = {33--43},
  doi = {10.12788/acp.0048}
}
Kostenlos starten →